The acquisition is the latest in a series of agreements between DePuy Synthes and organizations associated with entrepreneur Stéphane Lavallée.
J&J’s DePuy Synthes inks deal to buy orthopedic surgery tech Read More »
Apogee’s pipeline in a product drug zumilokibart achieved significant disease clearance in a mid-stage atopic dermatitis trial, but investors were miffed by a royalty financing deal with Blackstone.
Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss Read More »
The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been reported.
FDA veteran Peter Marks will now shape the future of Eli Lilly’s vaccines work after the buys of Curevo, LimmaTech Biologics and Vaccine Company for up to $3.8 billion total.
Lilly just bought renowned regulator Peter Marks a pipeline to play with Read More »
Nearly 80% of patients saw tumor shrinkage after being treated with Kura Oncology’s darlifarnib plus Bristol Myers Squibb’s Krazati, findings Mizuho analysts say could open up a $2 billion opportunity for the biotech.
Kura’s encouraging cancer drug data could unlock $2B market opportunity Read More »
The FDA will convene its vaccines advisory panel to discuss seasonal COVID-19 vaccines—a surprise move after Health Secretary and vaccine skeptic Robert F. Kennedy, Jr. overhauled a separate vaccine committee.
FDA assembles vaccine experts to update COVID-19 formulation Read More »
Under the temporary reign of top food executive Kyle Diamantas, the FDA will sustain programs initiated by former Commissioner Marty Makary, including the Commissioner’s National Priority Voucher initiative.
Makary’s reforms will live on at FDA even as leadership turns over Read More »
Eli Lilly continues to spend its GLP-1 landfall with four new deals in the past week, including three in the vaccine space; the obesity leader also touted surgery-like results for its next-gen weight loss drug; Moderna’s stock climbs on the hantavirus “fear trade”; and in oncology, all eyes are on Revolution at ASCO this week.
Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds Read More »
Despertarse sobresaltado después de soñar con una infidelidad puede sentirse como si acabáramos de recibir un balde de agua fría. Todo parece tan real y el desconcierto dura más tiempo del esperado. No obstante, los expertos en psicología aseguran que el sig …
¿Cuál ha sido el invento más disruptivo de la historia? Muchos pensarían inmediatamente en la rueda, la imprenta o el microchip. Sin embargo, la ciencia arqueológica y la antropología evolutiva apuntan hacia una herramienta mucho más humilde, pero inf …
